Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Here's the thing
View:
Post by biorun on Jun 28, 2023 1:37pm

Here's the thing

None, and I mean none of these updates mean a darn thing to the market UNTIL we see either $ in financial statements to signal a milestone payment by AbbVie, an announcement that they are market launching, or $ are received for any of the other pipelines.

Once revenue becomes a reality here, then these updates will mean one heck of a lot more to the street. I believe that will be the sling shot effect that could very likely play out.

The hard part is those data points could come tomorrow, next months, years or never.

What I keep coming back to is why the CEO put $500k after-tax cash into a boat load more shares. He knows, maybe, and we don't.
Comment by forhandlaren on Jun 29, 2023 2:30am
We need real numbers in order to deem the value of this company. For the moment the share trades between 13-14 cents, but if we had more information the range could be 40-50 or 120-130. Nevertheless, even though the last NR fuels the share price it's good to know that we're advancing on anti-viral which is a huge market. The COVID application is not very important any longer from a ...more  
Comment by biorun on Jun 29, 2023 9:23am
Link below: This is probably what will happen to Sirona, if we are to see those kinds of valuations. There is no way he or Geraldine or Chris will ever be able to exit stage right with their holdings without a manoeuvre like this. And I wouldn't be the least bit surprised if that has been the strategy all along as opposed to just growing the business logically and satisfying shareholders ...more  
Comment by Transperance on Jun 29, 2023 10:21am
  Secrecy or transparency? It would be nice if Sirona was to be acquired with a 700 or 800% bid premium like Sigilon, but is it likely? No shareholder can make such an assessment today. We have no figures to support such an evaluation. An alternative scenario for Sirona is bankruptcy. Further, as a shareholder, should I increase or decrease my Sirona position? What figures do we have to ...more  
Comment by PeterG on Jun 30, 2023 2:03am
What a fantastic comment!! Thanks for that. So true. Maybe Howard can spend 5 minutes from his valuable time to read this post. Cheers.
Comment by biorun on Jun 30, 2023 8:31am
Yes it is a good post in my view as well.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities